.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Julphar
Healthtrust
Federal Trade Commission
Mallinckrodt
Teva
Express Scripts
Baxter
Chinese Patent Office

Generated: February 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9508745

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-002Mar 16, 2005RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONITIS AND ABSCESSES
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-002Mar 16, 2005RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT PATIENTS
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-003Jun 27, 2006RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONITIS AND ABSCESSES
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-003Jun 27, 2006RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT PATIENTS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist